Progastrin, Novel Blood-Based Biomarker for Detection of Neuroendocrine Neoplasms
Clinicians and researchers at the University of Kentucky Division of Medical Oncology, College of Pharmacy, School of Medicine and Department of Surgical Oncology; ECS Progastrin in Switzerland; Centre Hospitalier Lyon-Sud in France; and Biospecimen…
READ MORE
2019 Monica Warner Award: Call for Nominations
Novartis has announced that nominations are open for the 10th Annual Monica Warner Award, which commemorates the life and work of Monica Warner as a driving force in the neuroendocrine tumor (NET) community. Nominations will be accepted until December…
READ MORE
Surgical Management of Neuroendocrine Tumors, November 21 Webinar for Patients and Caregivers
You’re invited to participate in a Neuroendocrine Tumor Awareness Month Webinar on November 21 from 7 to 9 pm, Eastern Time, presented by the American Association of Endocrine Surgeons (AAES). Four national experts will discuss the surgical management…
READ MORE
We SCAN! – INCA Launches First-Ever Global Survey to Measure Access Challenges to Optimal Neuroendocrine Tumor Care
In order to better understand the challenges of optimal care for neuroendocrine tumor (NET) patients, the International Neuroendocrine Cancer Alliance (INCA), of which the Carcinoid Cancer Foundation is a proud member, today launches SCAN –…
READ MORE
New York City Luncheon with the Experts on NET Cancer Day 2019
Join neuroendocrine tumor (NET) patients in New York City on Sunday, November 10, 2019 — NET Cancer Day — for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear…
READ MORE
Let’s Talk About NET Survivorship: An Evening for Neuroendocrine Cancer Patients and Caregivers
“Let’s Talk About NET Survivorship!” is a special evening presentation on Friday, June 28 for neuroendocrine cancer patients and caregivers and their health care providers. Attend in person at the Grand Hotel Minneapolis in Minneapolis, Minnesota…
READ MORE
Facebook Live Event Featuring Carcinoid Heart Disease Specialist Dr. Jerome Zacks, May 17
Join us this Friday, May 17th at 2:00 pm EST, for a special Facebook Live event! We’ll hear from neuroendocrine tumor (NET) expert Dr. Jerome S. Zacks, a cardiologist, during an in-depth discussion about Carcinoid Heart Disease.
Dr. Zacks has extensive…
READ MORE
Twitter Can Help Neuroendocrine Tumor Patients Understand Pathology
While the downsides of social media are getting a lot of attention in the news, we shouldn’t forget the technology’s incredible power to share useful information efficiently to all who need it. Enter Raul S. Gonzalez, MD, a pathologist at Beth Israel Deaconess…
READ MORE
Promising Developments in the Pipeline for High Grade Neuroendocrine Tumor Diagnosis and Treatment
“Treatment for high grade neuroendocrine neoplasms (abnormal tissue growth) is moving the way that the treatment for triple negative breast cancer is moving — toward the realization that there are a basket of subtypes and that each can be potentially…
READ MORE
Cytoreductive Surgery: Why, When, & How often?
The Carcinoid Cancer Foundation recently presented a Live Q&A session with Dr. Xavier Keutgen, discussing surgery for people living with neuroendocrine…
READ MORE
Carcinoid Cancer Foundation (CCF)
